Cerium dioxide nanoparticles do not modulate the lipopolysaccharide-induced inflammatory response in human monocytes

BACKGROUND: Cerium dioxide (CeO(2)) nanoparticles have potential therapeutic applications and are widely used for industrial purposes. However, the effects of these nanoparticles on primary human cells are largely unknown. The ability of nanoparticles to exacerbate pre-existing inflammatory disorder...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussain, Salik, Al-Nsour, Faris, Rice, Annette B, Marshburn, Jamie, Ji, Zhaoxia, Zink, Jeffery I, Yingling, Brenda, Walker, Nigel J, Garantziotis, Stavros
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3310407/
https://www.ncbi.nlm.nih.gov/pubmed/22457596
http://dx.doi.org/10.2147/IJN.S29429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3310407/
https://www.ncbi.nlm.nih.gov/pubmed/22457596
http://dx.doi.org/10.2147/IJN.S29429

Ejemplares similares